FORA Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,986
Closed -$242K 920
2021
Q1
$242K Sell
1,986
-13,560
-87% -$1.65M 0.08% 259
2020
Q4
$2.38M Buy
15,546
+15,029
+2,907% +$2.3M 0.36% 56
2020
Q3
$43K Sell
517
-10,198
-95% -$848K 0.03% 460
2020
Q2
$787K Buy
+10,715
New +$787K 0.27% 92
2020
Q1
Sell
-2,598
Closed -$158K 1080
2019
Q4
$158K Buy
+2,598
New +$158K 0.02% 669